SI-BONE, Inc. IPO Research Information

SI-BONE, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on SI-BONE, Inc. , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
SI-BONE, Inc.	SIBN - NASDAQ	$13.00-$15.00	$15.00	$21.00	7.2 million	10/17/2018
Underwriter(s): Morgan Stanley, BofA Merrill Lynch
Co-Manager(s): Canaccord Genuity, JMP Securities
Industry: Health Care
Filing(s): Filed 2018-09-20 Terms Added 2018-10-05

SI-BONE, Inc. Quote & Chart - Click for current quote - SIBN

About SI-BONE, Inc. (adapted from SI-BONE, Inc. prospectus):
They are a medical device company that has pioneered a proprietary minimally invasive surgical implant system, which they call iFuse, to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "SIBN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.